Paroxetine
Research News and Information

Saturday, November 21, 2009

Depletion of selective serotonin reuptake inhibitors during sewage sludge composting.

30 Oct 2009 Sewage and sewage sludge is known to contain pharmaceuticals, and since sewage sludge is often used as fertilizer within agriculture, the reduction of the selective serotonin reuptake inhibitors (SSRIs) Citalopram, Sertraline, Paroxetine, ... Read more...

[Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review]

19 Sep 2009 The data and the conclusions of the Cochrane review of drug therapy for the management of cancer related fatigue (CRF) is analysed and summarized in this report. Overall, data is weakened substantially by a high degree of heterogeneity that stems ... Read more...

Antidepressant medication use during breastfeeding.

30 Aug 2009 We performed an electronic search by using MEDLINE, PreMEDLINE, Current Contents, Biological Abstracts, and PsycINFO from June 2002 to December 2008 using the following terms: "antidepressant drugs", "antidepressive agents", "human milk", ... Read more...

Latest indexed articles for 'Paroxetine'

These are the very latest articles for this heading:

• Depletion of selective serotonin reuptake inhibitors during sewage sludge composting. 30 Oct 2009
• GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused son's heart defects. 13 Oct 2009
• GSK is sued in US over alleged link of paroxetine to birth defects. 10 Oct 2009
• [Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review] 19 Sep 2009
• Antidepressant medication use during breastfeeding. 30 Aug 2009
• Influence of the media on women taking antidepressants during pregnancy. 30 Aug 2009
• 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. 3 Aug 2009
• Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients. 30 Jul 2009
• Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder". 30 Jul 2009
• Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study. 30 Jul 2009
• Sex influences the effect of a lifelong increase in serotonin transporter function on cerebral metabolism. 30 Jul 2009
• TORDIA: unique opportunity to explore half-life theory. 30 Jul 2009
• The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease. 13 Jul 2009
• The effects of paroxetine on the pharmacokinetics of paliperidone extended-release tablets. 5 Jul 2009
• Role of nitric oxide in obsessive-compulsive behavior and its involvement in the anti-compulsive effect of paroxetine in mice. 3 Jul 2009
• Challenges in the identification and management of HSDD. 29 Jun 2009
• Investigating the efficacy of paroxetine in developmental stuttering. 29 Jun 2009
• Lessons continue: serotonin toxicity. 29 Jun 2009
• Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up. 26 Jun 2009
• Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone. 20 Jun 2009

See a longer list of these articles.

Technical information about 'Paroxetine'

Definition: A serotonin uptake inhibitor that is effective in the treatment of depression.

Chemical name: Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S-trans)-

Registry Number: 61869-08-7

Descriptor UI: D017374

Alternative terms: Paroxetine; Seroxat; FG-7051; Aropax; BRL-29060; BRL 29060; BRL29060; Paroxetine, trans-(+)-Isomer; Paroxetine Hydrochloride; Hydrochloride, Paroxetine; Paroxetine Hydrochloride, Hemihydrate; Hemihydrate Paroxetine Hydrochloride; Hydrochloride, Hemihydrate Paroxetine; Paroxetine Maleate; Maleate, Paroxetine; Paroxetine, cis-(+)-Isomer; Paroxetine, cis-(-)-Isomer; Paxil; Paroxetine Acetate; Acetate, Paroxetine;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Serotonin Uptake Inhibitors; Antidepressive Agents, Second-Generation;

Tree Number: D03.383.621.600;

Online Note: use PAROXETINE (NM) to search PAROXETINE 1980-92

History Note: 93; was PAROXETINE (NM) 1978-92